LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alterationCornelis M. van Tilburg, Olaf Witt, Samuel C. Blackman et al.|BMC Cancer|2024Cited by 66
Missense variants in the N-terminal domain of the A isoform of FHF2/FGF13 cause an X-linked developmental and epileptic encephalopathyAndrew E. Fry, Seo‐Kyung Chung, Christopher Marra et al.|The American Journal of Human Genetics|2020Cited by 48
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela‐Kristina Keck, David Jones, Andreas von Deimling et al.|Acta Neuropathologica|2022Cited by 44
European standard clinical practice recommendations for primary pediatric low-grade gliomasKleoniki Roka, A.Y.N. Schouten-Van Meeteren, Katrin Scheinemann et al.|EJC Paediatric Oncology|2024Cited by 9
Comparative Clinical and Imaging‐Based Evaluation of Therapeutic Modalities in CNS Embryonal Tumours With PLAGL AmplificationMichaela‐Kristina Keck, David Jones, Anna Tietze et al.|Neuropathology and Applied Neurobiology|2025Cited by 4